|
115
|
353
|
4wihA |
Crystal structure of camp-dependent protein kinase a from cricetulus griseus |
|
163
|
465
|
4wg4A |
Calcium-dependent protein kinase 1 from toxoplasma gondii (tgcdpk1) in complex with inhibitor uw1613 |
|
81
|
290
|
4x3fB |
Crystal structure of the intracellular domain of the m. tuberculosis ser/thr kinase pkna |
|
79
|
267
|
4uynA |
Sar156497 an exquisitely selective inhibitor of aurora kinases |
|
87
|
290
|
4wovA |
Crystal structure of tyrosine kinase 2 jh2 (pseudo kinase domain) complexed with bms-066 aka 2-methoxy-n-({6-[3-methyl-7-(methylamino)-3,5,8,10-tetraazatricyclo[7.3.0.0, 6]dodeca-1(9),2(6),4,7,11-pentaen-11-yl]pyridin-2-yl}methy l)acetamide |
|
66
|
256
|
4x7qA |
Pim2 kinase in complex with compound 1s |
|
79
|
275
|
4u5jA |
C-src in complex with ruxolitinib |
|
67
|
273
|
4rzvA |
Crystal structure of the braf (r509h) kinase domain monomer bound to vemurafenib |
|
71
|
273
|
4rzwA |
Crystal structure of braf (r509h) kinase domain bound to az628 |
|
84
|
308
|
4tygA |
Structural analysis of the human fibroblast growth factor receptor 4 kinase |
|
94
|
348
|
4tyhB |
Ternary complex of p38 and mk2 with a p38 inhibitor |
|
99
|
350
|
4tyhA |
Ternary complex of p38 and mk2 with a p38 inhibitor |
|
96
|
297
|
4twnA |
Human epha3 kinase domain in complex with birb796 |
|
94
|
290
|
4u8zA |
Crystal structure of mst3 with a pyrrolopyrimidine inhibitor (pf-06447475) |
|
106
|
357
|
4u79A |
Crystal structure of human jnk3 in complex with a benzenesulfonamide inhibitor. |
|
87
|
301
|
4rwlA |
Crystal structure of fgfr1 (c488a, c584c) in complex with 6-(7-((1-aminocyclopropyl) methoxy)-6-methoxyquinolin-4-yloxy)-n-methyl-1-naphthamide (e3810) |
|
81
|
298
|
4u43A |
Map4k4 in complex with inhibitor (compound 6) |
|
90
|
305
|
4rwiA |
Crystal structure of v561m fgfr1 gatekeeper mutation (c488a, c584s, v561m), apo |
|
79
|
273
|
4ty1A |
Crystal structure of human pim-1 kinase in complex with an aminooxadiazole-indole inhibitor. |
|
84
|
271
|
4twpA |
The crystal structure of human abl1 t315i gatekeeper mutant kinase domain in complex with axitinib |
|
110
|
334
|
4ub7A |
High-salt structure of protein kinase ck2 catalytic subunit with 4'-carboxy-6,8-bromo-flavonol (flc26) showing an extreme distortion of the atp-binding loop combined with a pi-halogen bond |
|
104
|
307
|
4tt7A |
Crystal structure of human alk with a covalent modification |
|
93
|
322
|
4u7zA |
Mitogen-activated protein kinase kinase (mek1) bound to g805 |
|
86
|
323
|
4tksA |
Native-sad phasing for human egfr kinase domain. |
|
114
|
352
|
4s31A |
Crystal structure of mitogen-activated protein kinase 1 wterk2 at 1.45a |
|
79
|
271
|
4rvmA |
Chk1 kinase domain with diazacarbazole compound 19 |
|
82
|
310
|
4tyjA |
Structural analysis of the human fibroblast growth factor receptor 4 kinase |
|
80
|
271
|
4rvlA |
Chk1 kinase domain with diazacarbazole compound 7: 3-(2-hydroxyphenyl)-9h-pyrrolo[2,3-b:5,4-c']dipyridine-6-carbonitrile |
|
67
|
305
|
4tyiA |
Structural analysis of the human fibroblast growth factor receptor 4 |
|
97
|
293
|
4u97A |
Crystal structure of asymmetric irak4 dimer |
|
105
|
294
|
4twcA |
2-benzamido-n-(1h-benzo[d]imidazol-2-yl)thiazole-4- carboxamide derivatives as potent inhibitors of ck1d/e |
|
98
|
292
|
4tn6A |
Ck1d in complex with inhibitor |
|
74
|
303
|
4tyeA |
Structural analysis of the human fibroblast growth factor receptor 4 kinase |
|
83
|
295
|
4u42A |
Map4k4 t181e mutant bound to inhibitor compound 1 |
|
104
|
352
|
4s30A |
Erk2 intrinsically active mutant (i84a) |
|
91
|
277
|
4rx9A |
Syk catalytic domain complexed with a potent pyrimidine inhibitor |
|
91
|
294
|
4tw9A |
Difluoro-dioxolo-benzoimidazol-benzamides as potent inhibitors of ck1delta and epsilon with nanomolar inhibitory activity on cancer cell proliferation |
|
86
|
319
|
4u80A |
Mek 1 kinase bound to g799 |
|
86
|
322
|
4u81A |
Mek1 kinase bound to small molecule inhibitor g659 |
|
104
|
351
|
4s34A |
Erk2 (i84a) in complex with amp-pnp |
|
111
|
351
|
4s2zA |
Erk2 intrinsically active mutant r65s |
|
82
|
295
|
4u3zA |
Apo map4k4 t181e phosphomimetic mutant |
|
90
|
308
|
4rwjA |
Crystal structure of fgfr1 (c488a, c584s) in complex with azd4547 (n-{3-[2-(3,5-dimethoxyphenyl)ethyl]-1h-pyrazol-5-yl}-4-[(3r,5s)-3,5-dimethylpiperazin-1-yl]benzamide) |
|
89
|
275
|
4rx8A |
Syk catalytic domain complexed with a potent triazine inhibitor2 |
|
88
|
276
|
4txcA |
Crystal structure of dapk1 kinase domain in complex with a small molecule inhibitor |
|
107
|
333
|
4ubaA |
Low-salt structure of protein kinase ck2 catalytic subunit with 4'-carboxy-6,8-bromo-flavonol (flc26) |
|
55
|
290
|
4tthB |
Crystal structure of a cdk6/vcyclin complex with inhibitor bound |
|
88
|
299
|
4u44A |
Map4k4 in complex with inhibitor (compound 16) |
|
85
|
271
|
4rvkA |
Chk1 kinase domain with diazacarbazole compound 8: n-[3-(6-cyano-9h-pyrrolo[2,3-b:5,4-c']dipyridin-3-yl)phenyl]acetamide |
|
158
|
466
|
4tzrA |
Calcium-dependent protein kinase 1 from toxoplasma gondii (tgcdpk1) in complex with inhibitor uw1561 |
